The ovarian cancer SIR was elevated overall (2.46; 95% CI 1.23–4.92; P=0.01) and for mothers and sisters of BRCA1 mutation carriers (P<0.001), but not for mothers and sisters of index cases who tested negative or were not tested; see also Figure 2. The gene discussed is BRCA1; the disease is ovarian carcinoma.